Drug Description in Trials / DrugBank / KEGG DRUG


Search results


No. 薬物名(臨床試験情報から抽出) DrugBank KEGG DRUG KEGG GENES KEGG PATHWAY 指定難病告示番号
11H/31P magnetic resonance spectroscopy----1件: 77 💬
276517-01-4----1件: 77 💬
381409-90-7----1件: 77 💬
4Acetaminophen1件: Acetaminophen1件: Acetaminophen 💬 2件: PTGS1,
PTGS2 💬
23件: Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Efferocytosis, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬14件: 11, 19, 34, 46, 49, 51, 70, 77, 86, 96, 222, 256, 300, 337 💬
5Acetato DE octreótida----1件: 77 💬
6Adipose tissue biopsy----1件: 77 💬
7Alesse----1件: 77 💬
8ATL1103----1件: 77 💬
9Avandia*28CPR RIV 4MG1件: Rosiglitazone2件: Rosiglitazone maleate ,
Rosiglitazone 💬
1件: NR1C3 💬 12件: AMPK signaling pathway, Efferocytosis, Huntington disease, Lipid and atherosclerosis, Longevity regulating pathway, Non-alcoholic fatty liver disease, Osteoclast differentiation, PPAR signaling pathway, Pathways in cancer, Thermogenesis, Thyroid cancer, Transcriptional misregulation in cancer 💬1件: 77 💬
10BIM 23a760----1件: 77 💬
11BIM23a760----1件: 77 💬
12BIM23b065----1件: 77 💬
13Blood tests: IGF-1, AST/ALT/ALP/tbil, GTT----1件: 77 💬
14C2L-OCT-01 PR----1件: 77 💬
15C2L-OCT-01 PR , 10MG----1件: 77 💬
16C2L-OCT-01 PR , 20MG----1件: 77 💬
17C2L-OCT-01 PR , 30MG----1件: 77 💬
18C2L-OCT-01 PR 30 MG----1件: 77 💬
19C2L-OCT-01 PR, 10 or 20 MG----1件: 77 💬
20C2L-OCT-01 PR, 20 MG----1件: 77 💬
21C2L-OCT-01 PR, 30 MG----1件: 77 💬
22Cabaser----2件: 6, 77 💬
23Cabergolin----1件: 77 💬
24Cabergoline1件: Cabergoline1件: Cabergoline 💬 2件: DRD2,
PRL 💬
14件: Alcoholism, Cocaine addiction, Cytokine-cytokine receptor interaction, Dopaminergic synapse, Gap junction, Hormone signaling, JAK-STAT signaling pathway, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway, Parkinson disease, Prolactin signaling pathway, Rap1 signaling pathway, cAMP signaling pathway 💬4件: 6, 74, 75, 77 💬
25CAM2029----1件: 77 💬
26CAM2029 (octreotide subcutaneous depot) _prefilled syringe_prefilled syringe1件: Octreotide4件: Octreotide ,
Octreotide acetate ,
Octreotide pamoate ,
Octreotide acetate 💬
1件: SSTR2 💬 5件: Gastric acid secretion, Growth hormone synthesis, secretion and action, Hormone signaling, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬1件: 77 💬
27CAM2029 (octreotide subcutaneous depot)_ prefilled PEN1件: Octreotide4件: Octreotide ,
Octreotide acetate ,
Octreotide pamoate ,
Octreotide acetate 💬
1件: SSTR2 💬 5件: Gastric acid secretion, Growth hormone synthesis, secretion and action, Hormone signaling, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬1件: 77 💬
28CAM2029 (octreotide subcutaneous depot)_ prefilled syringe1件: Octreotide4件: Octreotide ,
Octreotide acetate ,
Octreotide pamoate ,
Octreotide acetate 💬
1件: SSTR2 💬 5件: Gastric acid secretion, Growth hormone synthesis, secretion and action, Hormone signaling, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬1件: 77 💬
29CAM2029 (octreotide subcutaneous depot)_pre-filled PEN1件: Octreotide4件: Octreotide ,
Octreotide acetate ,
Octreotide pamoate ,
Octreotide acetate 💬
1件: SSTR2 💬 5件: Gastric acid secretion, Growth hormone synthesis, secretion and action, Hormone signaling, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬1件: 77 💬
30CAM2029 (octreotide subcutaneous depot)_pre-filled syringe1件: Octreotide4件: Octreotide ,
Octreotide acetate ,
Octreotide pamoate ,
Octreotide acetate 💬
1件: SSTR2 💬 5件: Gastric acid secretion, Growth hormone synthesis, secretion and action, Hormone signaling, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬1件: 77 💬
31CAM2029 (octreotide subcutaneous depot)_prefilled PEN1件: Octreotide4件: Octreotide ,
Octreotide acetate ,
Octreotide pamoate ,
Octreotide acetate 💬
1件: SSTR2 💬 5件: Gastric acid secretion, Growth hormone synthesis, secretion and action, Hormone signaling, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬1件: 77 💬
32CAM2029 (octreotide subcutaneous depot)_prefilled syringe1件: Octreotide4件: Octreotide ,
Octreotide acetate ,
Octreotide pamoate ,
Octreotide acetate 💬
1件: SSTR2 💬 5件: Gastric acid secretion, Growth hormone synthesis, secretion and action, Hormone signaling, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬1件: 77 💬
33CAM2029-BR----1件: 77 💬
34Cialis - 20 MG 2 compresse rivestite CON film IN blister USO orale1件: Tadalafil1件: Tadalafil 💬 1件: PDE5 💬 2件: Purine metabolism, cGMP-PKG signaling pathway 💬2件: 75, 77 💬
35Clomiphene citrate1件: Clomifene2件: Clomiphene citrate ,
Clomifene 💬
2件: ESR1,
ESR2 💬
10件: Breast cancer, Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Estrogen signaling pathway, GnRH secretion, Hormone signaling, Pathways in cancer, Prolactin signaling pathway, Proteoglycans in cancer, Thyroid hormone signaling pathway 💬2件: 74, 77 💬
36Cmri----3件: 51, 77, 86 💬
37Combination with dopamine agonist cabergoline----1件: 77 💬
38Combination with somatostatin analogue octreotide----1件: 77 💬
39CRN00808----1件: 77 💬
40CRN00808 IS AN oral NON-peptide small molecule somatostatin receptor 2 (SST2) agonist1件: Somatostatin1件: Somatostatin 💬 5件: SSTR1,
SSTR2,
SSTR3,
SSTR4,
SSTR5 💬
5件: Gastric acid secretion, Growth hormone synthesis, secretion and action, Hormone signaling, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬1件: 77 💬
41CRN00808 è UN agonista DEL recettore 2 della somatostatina (SST2), orale, NON peptidico A piccole dimensioni molecolari----1件: 77 💬
42CRN00808.HCL----1件: 77 💬
43Cyclo ((diaminoethyl-carbamate)hypro-PHG-(D) TRP-LY pamoate----1件: 77 💬
44Cyclo((diaminoethyl-carbamate)hypro-PHG-(D)TRP-LY pamoate----1件: 77 💬
45Cyclo((diaminoethyl-carbamate)hypro-PHG-(D)TRP-LYS pamoate----1件: 77 💬
46Cyclo((diaminoethyl-carbamate)hypro-PHG-(D)TRP-LYS-TYR(BZL)-PHE) pamoate----1件: 77 💬
47D-phenylalanyl-L-H----1件: 77 💬
48D-phenylalanyl-L-HE----1件: 77 💬
49D-phenylalanyl-L-hemicystyl-L-phenylalanyl-D-trypto----1件: 77 💬
50D-phenylalanyl-L-hemicystyl-L-phenylalanyl-D-tryptophan----1件: 77 💬
51D-phenylalanyl-L-hemicystyl-L-phenylalanyl-D-tryptophyl-L-lysyl-L-threonyl-L-hemiscystyl-L-threonino----1件: 77 💬
52Debio 4126----1件: 77 💬
53Denosumab1件: Denosumab1件: Denosumab 💬 1件: TNFSF11 💬 8件: Breast cancer, Chemical carcinogenesis - receptor activation, Cytokine-cytokine receptor interaction, NF-kappa B signaling pathway, Osteoclast differentiation, Parathyroid hormone synthesis, secretion and action, Prolactin signaling pathway, Rheumatoid arthritis 💬10件: 46, 50, 70, 75, 77, 93, 95, 96, 274, 299 💬
54DG3173----1件: 77 💬
55Direct surgery FOR acromegaly----1件: 77 💬
56Dopamine1件: Dopamine2件: Dopamine hydrochloride ,
Dopamine 💬
5件: DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬
13件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬3件: 6, 7, 77 💬
57Dopastatin1件: Dopastatin---1件: 77 💬
58Dostinex1件: Cabergoline1件: Cabergoline 💬 2件: DRD2,
PRL 💬
14件: Alcoholism, Cocaine addiction, Cytokine-cytokine receptor interaction, Dopaminergic synapse, Gap junction, Hormone signaling, JAK-STAT signaling pathway, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway, Parkinson disease, Prolactin signaling pathway, Rap1 signaling pathway, cAMP signaling pathway 💬2件: 75, 77 💬
59Dostinex 0,5 MG tabletten----1件: 77 💬
60Dostinex 0.5MG tabletts1件: Cabergoline1件: Cabergoline 💬 2件: DRD2,
PRL 💬
14件: Alcoholism, Cocaine addiction, Cytokine-cytokine receptor interaction, Dopaminergic synapse, Gap junction, Hormone signaling, JAK-STAT signaling pathway, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway, Parkinson disease, Prolactin signaling pathway, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 77 💬
61Dostinex 2CPR 0,5MG1件: Cabergoline1件: Cabergoline 💬 2件: DRD2,
PRL 💬
14件: Alcoholism, Cocaine addiction, Cytokine-cytokine receptor interaction, Dopaminergic synapse, Gap junction, Hormone signaling, JAK-STAT signaling pathway, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway, Parkinson disease, Prolactin signaling pathway, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 77 💬
62Empagliflozin1件: Empagliflozin1件: Empagliflozin 💬 --10件: 65, 67, 72, 77, 86, 96, 97, 257, 298, 299 💬
63Escitalopram 10 MG1件: Escitalopram2件: Escitalopram oxalate ,
Escitalopram 💬
1件: SLC6A4 💬 3件: Neuroactive ligand signaling, Serotonergic synapse, Synaptic vesicle cycle 💬1件: 77 💬
64Escitalopram hexal 10 MG1件: Escitalopram2件: Escitalopram oxalate ,
Escitalopram 💬
1件: SLC6A4 💬 3件: Neuroactive ligand signaling, Serotonergic synapse, Synaptic vesicle cycle 💬1件: 77 💬
65Evista 60MG FILM-coated tablets1件: Raloxifene2件: Raloxifene hydrochloride ,
Raloxifene 💬
2件: ESR1,
ESR2 💬
10件: Breast cancer, Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Estrogen signaling pathway, GnRH secretion, Hormone signaling, Pathways in cancer, Prolactin signaling pathway, Proteoglycans in cancer, Thyroid hormone signaling pathway 💬1件: 77 💬
66Furosemide1件: Furosemide1件: Furosemide 💬 1件: SLC12A2 💬 3件: Pancreatic secretion, Salivary secretion, Vibrio cholerae infection 💬2件: 77, 86 💬
67Gadolinium1件: Gadolinium---4件: 46, 77, 86, 305 💬
68Gamma knife radiosurgery----1件: 77 💬
69Genotropin1件: Somatotropin1件: Somatropin 💬 1件: GHR 💬 6件: Cytokine-cytokine receptor interaction, Growth hormone synthesis, secretion and action, Hormone signaling, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway 💬5件: 13, 77, 107, 187, 193 💬
70GHR-LRX----1件: 77 💬
71Glucose1件: Dextrose, unspecified form2件: Dextrose ,
Glucose, liquid 💬
--9件: 6, 13, 66, 77, 96, 97, 226, 254, 299 💬
72Growth hormone1件: Somatotropin1件: Somatropin 💬 1件: GHR 💬 6件: Cytokine-cytokine receptor interaction, Growth hormone synthesis, secretion and action, Hormone signaling, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway 💬16件: 2, 19, 46, 77, 78, 96, 97, 107, 113, 156, 191, 193, 195, 238, 265, 299 💬
73Growth hormone receptor antagonist1件: Somatotropin1件: Somatropin 💬 1件: GHR 💬 6件: Cytokine-cytokine receptor interaction, Growth hormone synthesis, secretion and action, Hormone signaling, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway 💬1件: 77 💬
74H01C B03----1件: 77 💬
75Home administration----1件: 77 💬
76Implante DE octreótida----1件: 77 💬
77Insulin----6件: 6, 13, 46, 75, 77, 299 💬
78Ionis GHR-LRX----1件: 77 💬
79Ionis-GHR-LRX----1件: 77 💬
80Ipstyl----1件: 77 💬
81Ipstyl - 60 MG soluzione iniettabile PER USO sottocutaneo 1 siringa preriempita----1件: 77 💬
82Ipstyl - 90 MG soluzione iniettabile PER USO sottocutaneo 1 siringa preriempita----1件: 77 💬
83Ipstyl 120 MG----1件: 77 💬
84Ipstyl 90 MG----1件: 77 💬
85Ipstyl autogel----1件: 77 💬
86Isis 766720----1件: 77 💬
87IT IS A chimera OF A dopamin 2 and AN somatostatin 2 receptor agonist----1件: 77 💬
88ITF2984 1000 MCG----1件: 77 💬
89ITF2984 2000 MCG----1件: 77 💬
90ITF2984 500 MCG----1件: 77 💬
91ITF2984 diacetate----1件: 77 💬
92Ketogenic diet----9件: 13, 19, 21, 49, 67, 77, 127, 145, 148 💬
93Lanreotida autogel 120 MG1件: Lanreotide1件: Lanreotide acetate 💬 2件: SSTR2,
SSTR5 💬
5件: Gastric acid secretion, Growth hormone synthesis, secretion and action, Hormone signaling, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬1件: 77 💬
94Lanreotide1件: Lanreotide1件: Lanreotide acetate 💬 2件: SSTR2,
SSTR5 💬
5件: Gastric acid secretion, Growth hormone synthesis, secretion and action, Hormone signaling, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬3件: 67, 73, 77 💬
95Lanreotide (autogel formulation), duration OF treatment 24-56 weeks, depending ON dose interval1件: Lanreotide1件: Lanreotide acetate 💬 2件: SSTR2,
SSTR5 💬
5件: Gastric acid secretion, Growth hormone synthesis, secretion and action, Hormone signaling, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬1件: 77 💬
96Lanreotide (autogel formulation), duration OF treatment 46-48 weeks1件: Lanreotide1件: Lanreotide acetate 💬 2件: SSTR2,
SSTR5 💬
5件: Gastric acid secretion, Growth hormone synthesis, secretion and action, Hormone signaling, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬1件: 77 💬
97Lanreotide 60MG solution FOR injection1件: Lanreotide1件: Lanreotide acetate 💬 2件: SSTR2,
SSTR5 💬
5件: Gastric acid secretion, Growth hormone synthesis, secretion and action, Hormone signaling, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬1件: 77 💬
98Lanreotide acetate1件: Lanreotide1件: Lanreotide acetate 💬 2件: SSTR2,
SSTR5 💬
5件: Gastric acid secretion, Growth hormone synthesis, secretion and action, Hormone signaling, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬4件: 67, 77, 85, 298 💬
99Lanreotide acetato1件: Lanreotide1件: Lanreotide acetate 💬 2件: SSTR2,
SSTR5 💬
5件: Gastric acid secretion, Growth hormone synthesis, secretion and action, Hormone signaling, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬1件: 77 💬
100Lanreotide ATG1件: Lanreotide1件: Lanreotide acetate 💬 2件: SSTR2,
SSTR5 💬
5件: Gastric acid secretion, Growth hormone synthesis, secretion and action, Hormone signaling, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬1件: 77 💬
101Lanreotide ATG 120MG1件: Lanreotide1件: Lanreotide acetate 💬 2件: SSTR2,
SSTR5 💬
5件: Gastric acid secretion, Growth hormone synthesis, secretion and action, Hormone signaling, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬1件: 77 💬
102Lanreotide autogel1件: Lanreotide1件: Lanreotide acetate 💬 2件: SSTR2,
SSTR5 💬
5件: Gastric acid secretion, Growth hormone synthesis, secretion and action, Hormone signaling, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬1件: 77 💬
103Lanreotide autogel 120 MG1件: Lanreotide1件: Lanreotide acetate 💬 2件: SSTR2,
SSTR5 💬
5件: Gastric acid secretion, Growth hormone synthesis, secretion and action, Hormone signaling, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬1件: 77 💬
104Lanreotide autogel 120MG1件: Lanreotide1件: Lanreotide acetate 💬 2件: SSTR2,
SSTR5 💬
5件: Gastric acid secretion, Growth hormone synthesis, secretion and action, Hormone signaling, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬1件: 77 💬
105Lanreotide autogel and octreotide LAR1件: Lanreotide1件: Lanreotide acetate 💬 2件: SSTR2,
SSTR5 💬
5件: Gastric acid secretion, Growth hormone synthesis, secretion and action, Hormone signaling, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬1件: 77 💬
106Lanreotide PRF1件: Lanreotide1件: Lanreotide acetate 💬 2件: SSTR2,
SSTR5 💬
5件: Gastric acid secretion, Growth hormone synthesis, secretion and action, Hormone signaling, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬1件: 77 💬
107Lanreotide-autogel 120 MG1件: Lanreotide1件: Lanreotide acetate 💬 2件: SSTR2,
SSTR5 💬
5件: Gastric acid secretion, Growth hormone synthesis, secretion and action, Hormone signaling, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬1件: 77 💬
108Liraglutide1件: Liraglutide1件: Liraglutide 💬 1件: GLP1R 💬 4件: Hormone signaling, Insulin secretion, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬5件: 6, 13, 75, 77, 193 💬
109Medical history, demographics----1件: 77 💬
110Medications FOR acromegaly----1件: 77 💬
111Mediterranean diet----6件: 13, 77, 96, 97, 265, 299 💬
112Metformin1件: Metformin2件: Metformin hydrochloride ,
Metformin 💬
2件: PRKAA,
PRKAA 💬
20件: AMPK signaling pathway, Adipocytokine signaling pathway, Alcoholic liver disease, Apelin signaling pathway, Autophagy - animal, Circadian rhythm, Fluid shear stress and atherosclerosis, FoxO signaling pathway, Glucagon signaling pathway, Hypertrophic cardiomyopathy, Insulin resistance, Insulin signaling pathway, Longevity regulating pathway, Longevity regulating pathway - multiple species, Non-alcoholic fatty liver disease, Oxytocin signaling pathway, PI3K-Akt signaling pathway, Thermogenesis, Tight junction, mTOR signaling pathway 💬23件: 2, 6, 8, 13, 46, 49, 60, 65, 66, 67, 75, 77, 84, 86, 97, 113, 127, 206, 218, 225, 265, 285, 298 💬
113Mycapssa1件: Octreotide4件: Octreotide ,
Octreotide acetate ,
Octreotide pamoate ,
Octreotide acetate 💬
1件: SSTR2 💬 5件: Gastric acid secretion, Growth hormone synthesis, secretion and action, Hormone signaling, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬1件: 77 💬
114Octreolin----1件: 77 💬
115Octreotid----1件: 77 💬
116Octreotida1件: Octreotide4件: Octreotide ,
Octreotide acetate ,
Octreotide pamoate ,
Octreotide acetate 💬
1件: SSTR2 💬 5件: Gastric acid secretion, Growth hormone synthesis, secretion and action, Hormone signaling, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬1件: 77 💬
117Octreotida acetato1件: Octreotide4件: Octreotide ,
Octreotide acetate ,
Octreotide pamoate ,
Octreotide acetate 💬
1件: SSTR2 💬 5件: Gastric acid secretion, Growth hormone synthesis, secretion and action, Hormone signaling, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬1件: 77 💬
118Octreotidacetat----1件: 77 💬
119Octreotide1件: Octreotide4件: Octreotide ,
Octreotide acetate ,
Octreotide pamoate ,
Octreotide acetate 💬
1件: SSTR2 💬 5件: Gastric acid secretion, Growth hormone synthesis, secretion and action, Hormone signaling, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬8件: 67, 75, 77, 84, 85, 89, 193, 227 💬
120Octreotide acetate1件: Octreotide4件: Octreotide ,
Octreotide acetate ,
Octreotide pamoate ,
Octreotide acetate 💬
1件: SSTR2 💬 5件: Gastric acid secretion, Growth hormone synthesis, secretion and action, Hormone signaling, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬2件: 77, 227 💬
121Octreotide acetate 30 MG suspension1件: Octreotide4件: Octreotide ,
Octreotide acetate ,
Octreotide pamoate ,
Octreotide acetate 💬
1件: SSTR2 💬 5件: Gastric acid secretion, Growth hormone synthesis, secretion and action, Hormone signaling, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬1件: 77 💬
122Octreotide acetate and cabergoline/octrotide and somavert1件: Octreotide4件: Octreotide ,
Octreotide acetate ,
Octreotide pamoate ,
Octreotide acetate 💬
1件: SSTR2 💬 5件: Gastric acid secretion, Growth hormone synthesis, secretion and action, Hormone signaling, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬1件: 77 💬
123Octreotide acetate microspheres FOR injection injection1件: Octreotide4件: Octreotide ,
Octreotide acetate ,
Octreotide pamoate ,
Octreotide acetate 💬
1件: SSTR2 💬 5件: Gastric acid secretion, Growth hormone synthesis, secretion and action, Hormone signaling, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬1件: 77 💬
124Octreotide acetate prolonged release, 30 MG1件: Octreotide4件: Octreotide ,
Octreotide acetate ,
Octreotide pamoate ,
Octreotide acetate 💬
1件: SSTR2 💬 5件: Gastric acid secretion, Growth hormone synthesis, secretion and action, Hormone signaling, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬1件: 77 💬
125Octreotide acetato1件: Octreotide4件: Octreotide ,
Octreotide acetate ,
Octreotide pamoate ,
Octreotide acetate 💬
1件: SSTR2 💬 5件: Gastric acid secretion, Growth hormone synthesis, secretion and action, Hormone signaling, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬2件: 77, 227 💬
126Octreotide capsules1件: Octreotide4件: Octreotide ,
Octreotide acetate ,
Octreotide pamoate ,
Octreotide acetate 💬
1件: SSTR2 💬 5件: Gastric acid secretion, Growth hormone synthesis, secretion and action, Hormone signaling, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬1件: 77 💬
127Octreotide fluidcrystal® injection depot1件: Octreotide4件: Octreotide ,
Octreotide acetate ,
Octreotide pamoate ,
Octreotide acetate 💬
1件: SSTR2 💬 5件: Gastric acid secretion, Growth hormone synthesis, secretion and action, Hormone signaling, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬1件: 77 💬
128Octreotide hydrochloride1件: Octreotide4件: Octreotide ,
Octreotide acetate ,
Octreotide pamoate ,
Octreotide acetate 💬
1件: SSTR2 💬 5件: Gastric acid secretion, Growth hormone synthesis, secretion and action, Hormone signaling, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬1件: 77 💬
129Octreotide implant1件: Octreotide4件: Octreotide ,
Octreotide acetate ,
Octreotide pamoate ,
Octreotide acetate 💬
1件: SSTR2 💬 5件: Gastric acid secretion, Growth hormone synthesis, secretion and action, Hormone signaling, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬1件: 77 💬
130Octreotide LAR1件: Octreotide4件: Octreotide ,
Octreotide acetate ,
Octreotide pamoate ,
Octreotide acetate 💬
1件: SSTR2 💬 5件: Gastric acid secretion, Growth hormone synthesis, secretion and action, Hormone signaling, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬3件: 67, 77, 227 💬
131Octreotide LAR 30 MG injection1件: Octreotide4件: Octreotide ,
Octreotide acetate ,
Octreotide pamoate ,
Octreotide acetate 💬
1件: SSTR2 💬 5件: Gastric acid secretion, Growth hormone synthesis, secretion and action, Hormone signaling, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬1件: 77 💬
132Octreotide LAR 30MG1件: Octreotide4件: Octreotide ,
Octreotide acetate ,
Octreotide pamoate ,
Octreotide acetate 💬
1件: SSTR2 💬 5件: Gastric acid secretion, Growth hormone synthesis, secretion and action, Hormone signaling, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬1件: 77 💬
133Octreotide-LAR1件: Octreotide4件: Octreotide ,
Octreotide acetate ,
Octreotide pamoate ,
Octreotide acetate 💬
1件: SSTR2 💬 5件: Gastric acid secretion, Growth hormone synthesis, secretion and action, Hormone signaling, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬2件: 67, 77 💬
134Octreotide-LAR or lanreotide1件: Octreotide4件: Octreotide ,
Octreotide acetate ,
Octreotide pamoate ,
Octreotide acetate 💬
1件: SSTR2 💬 5件: Gastric acid secretion, Growth hormone synthesis, secretion and action, Hormone signaling, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬1件: 77 💬
135Ogtt----2件: 77, 299 💬
136ONO-5788----1件: 77 💬
137Oral glucose tolerance test----6件: 6, 13, 77, 160, 195, 299 💬
138Oral glucose tolerance testing----1件: 77 💬
139Paltusotine1件: Paltusotine1件: Paltusotine 💬 1件: SSTR2 💬 5件: Gastric acid secretion, Growth hormone synthesis, secretion and action, Hormone signaling, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬1件: 77 💬
140Paltusotine (free base)1件: Paltusotine1件: Paltusotine 💬 1件: SSTR2 💬 5件: Gastric acid secretion, Growth hormone synthesis, secretion and action, Hormone signaling, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬1件: 77 💬
141Pasireotida1件: Pasireotide3件: Pasireotide ,
Pasireotide diaspartate ,
Pasireotide pamoate 💬
4件: SSTR1,
SSTR2,
SSTR3,
SSTR5 💬
5件: Gastric acid secretion, Growth hormone synthesis, secretion and action, Hormone signaling, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬1件: 77 💬
142Pasireotide1件: Pasireotide3件: Pasireotide ,
Pasireotide diaspartate ,
Pasireotide pamoate 💬
4件: SSTR1,
SSTR2,
SSTR3,
SSTR5 💬
5件: Gastric acid secretion, Growth hormone synthesis, secretion and action, Hormone signaling, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬3件: 74, 75, 77 💬
143Pasireotide 20MG1件: Pasireotide3件: Pasireotide ,
Pasireotide diaspartate ,
Pasireotide pamoate 💬
4件: SSTR1,
SSTR2,
SSTR3,
SSTR5 💬
5件: Gastric acid secretion, Growth hormone synthesis, secretion and action, Hormone signaling, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬2件: 75, 77 💬
144Pasireotide 40MG1件: Pasireotide3件: Pasireotide ,
Pasireotide diaspartate ,
Pasireotide pamoate 💬
4件: SSTR1,
SSTR2,
SSTR3,
SSTR5 💬
5件: Gastric acid secretion, Growth hormone synthesis, secretion and action, Hormone signaling, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬2件: 75, 77 💬
145Pasireotide 60MG1件: Pasireotide3件: Pasireotide ,
Pasireotide diaspartate ,
Pasireotide pamoate 💬
4件: SSTR1,
SSTR2,
SSTR3,
SSTR5 💬
5件: Gastric acid secretion, Growth hormone synthesis, secretion and action, Hormone signaling, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬2件: 75, 77 💬
146Pasireotide diaspartate1件: Pasireotide3件: Pasireotide ,
Pasireotide diaspartate ,
Pasireotide pamoate 💬
4件: SSTR1,
SSTR2,
SSTR3,
SSTR5 💬
5件: Gastric acid secretion, Growth hormone synthesis, secretion and action, Hormone signaling, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬2件: 75, 77 💬
147Pasireotide LAR1件: Pasireotide3件: Pasireotide ,
Pasireotide diaspartate ,
Pasireotide pamoate 💬
4件: SSTR1,
SSTR2,
SSTR3,
SSTR5 💬
5件: Gastric acid secretion, Growth hormone synthesis, secretion and action, Hormone signaling, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬3件: 67, 75, 77 💬
148Pasireotide LAR 60 MG1件: Pasireotide3件: Pasireotide ,
Pasireotide diaspartate ,
Pasireotide pamoate 💬
4件: SSTR1,
SSTR2,
SSTR3,
SSTR5 💬
5件: Gastric acid secretion, Growth hormone synthesis, secretion and action, Hormone signaling, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬1件: 77 💬
149Pasireotide long acting release formulation1件: Pasireotide3件: Pasireotide ,
Pasireotide diaspartate ,
Pasireotide pamoate 💬
4件: SSTR1,
SSTR2,
SSTR3,
SSTR5 💬
5件: Gastric acid secretion, Growth hormone synthesis, secretion and action, Hormone signaling, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬1件: 77 💬
150Pasireotide pamoate1件: Pasireotide3件: Pasireotide ,
Pasireotide diaspartate ,
Pasireotide pamoate 💬
4件: SSTR1,
SSTR2,
SSTR3,
SSTR5 💬
5件: Gastric acid secretion, Growth hormone synthesis, secretion and action, Hormone signaling, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬2件: 75, 77 💬
151Pegvisomant1件: Pegvisomant1件: Pegvisomant 💬 1件: GHR 💬 6件: Cytokine-cytokine receptor interaction, Growth hormone synthesis, secretion and action, Hormone signaling, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway 💬2件: 77, 265 💬
152Pegvisomant treatment1件: Pegvisomant1件: Pegvisomant 💬 1件: GHR 💬 6件: Cytokine-cytokine receptor interaction, Growth hormone synthesis, secretion and action, Hormone signaling, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway 💬1件: 77 💬
153Pegvisomant/ sandostatin LAR1件: Pegvisomant1件: Pegvisomant 💬 1件: GHR 💬 6件: Cytokine-cytokine receptor interaction, Growth hormone synthesis, secretion and action, Hormone signaling, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway 💬1件: 77 💬
154PHE----2件: 75, 77 💬
155PN-800467----1件: 77 💬
156PRE-treatment with octreotide----1件: 77 💬
157Preoperative lanreotide treatment----1件: 77 💬
158Radiotherapy----1件: 77 💬
159Raloxifene1件: Raloxifene2件: Raloxifene hydrochloride ,
Raloxifene 💬
2件: ESR1,
ESR2 💬
10件: Breast cancer, Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Estrogen signaling pathway, GnRH secretion, Hormone signaling, Pathways in cancer, Prolactin signaling pathway, Proteoglycans in cancer, Thyroid hormone signaling pathway 💬1件: 77 💬
160Recombinant human growth hormone1件: Somatotropin1件: Somatropin 💬 1件: GHR 💬 6件: Cytokine-cytokine receptor interaction, Growth hormone synthesis, secretion and action, Hormone signaling, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway 💬4件: 77, 193, 265, 276 💬
161Rosiglitazone1件: Rosiglitazone2件: Rosiglitazone maleate ,
Rosiglitazone 💬
1件: NR1C3 💬 12件: AMPK signaling pathway, Efferocytosis, Huntington disease, Lipid and atherosclerosis, Longevity regulating pathway, Non-alcoholic fatty liver disease, Osteoclast differentiation, PPAR signaling pathway, Pathways in cancer, Thermogenesis, Thyroid cancer, Transcriptional misregulation in cancer 💬3件: 77, 97, 222 💬
162Saline1件: Sodium chloride1件: Sodium chloride 💬 --19件: 2, 6, 13, 17, 18, 46, 53, 67, 77, 86, 96, 97, 98, 168, 256, 271, 274, 299, 301 💬
163Sandostatin1件: Octreotide4件: Octreotide ,
Octreotide acetate ,
Octreotide pamoate ,
Octreotide acetate 💬
1件: SSTR2 💬 5件: Gastric acid secretion, Growth hormone synthesis, secretion and action, Hormone signaling, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬1件: 77 💬
164Sandostatin LAR1件: Octreotide4件: Octreotide ,
Octreotide acetate ,
Octreotide pamoate ,
Octreotide acetate 💬
1件: SSTR2 💬 5件: Gastric acid secretion, Growth hormone synthesis, secretion and action, Hormone signaling, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬4件: 67, 77, 84, 193 💬
165Sandostatin LAR 10 MG polvo para suspensióN inyectable1件: Octreotide4件: Octreotide ,
Octreotide acetate ,
Octreotide pamoate ,
Octreotide acetate 💬
1件: SSTR2 💬 5件: Gastric acid secretion, Growth hormone synthesis, secretion and action, Hormone signaling, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬1件: 77 💬
166Sandostatin LAR 10MG1件: Octreotide4件: Octreotide ,
Octreotide acetate ,
Octreotide pamoate ,
Octreotide acetate 💬
1件: SSTR2 💬 5件: Gastric acid secretion, Growth hormone synthesis, secretion and action, Hormone signaling, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬1件: 77 💬
167Sandostatin LAR 20 MG polvo para suspensióN inyectable1件: Octreotide4件: Octreotide ,
Octreotide acetate ,
Octreotide pamoate ,
Octreotide acetate 💬
1件: SSTR2 💬 5件: Gastric acid secretion, Growth hormone synthesis, secretion and action, Hormone signaling, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬1件: 77 💬
168Sandostatin LAR 20MG1件: Octreotide4件: Octreotide ,
Octreotide acetate ,
Octreotide pamoate ,
Octreotide acetate 💬
1件: SSTR2 💬 5件: Gastric acid secretion, Growth hormone synthesis, secretion and action, Hormone signaling, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬1件: 77 💬
169Sandostatin LAR 20MG, 30MG1件: Octreotide4件: Octreotide ,
Octreotide acetate ,
Octreotide pamoate ,
Octreotide acetate 💬
1件: SSTR2 💬 5件: Gastric acid secretion, Growth hormone synthesis, secretion and action, Hormone signaling, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬1件: 77 💬
170Sandostatin LAR 30 MG polvo para suspensióN inyectable1件: Octreotide4件: Octreotide ,
Octreotide acetate ,
Octreotide pamoate ,
Octreotide acetate 💬
1件: SSTR2 💬 5件: Gastric acid secretion, Growth hormone synthesis, secretion and action, Hormone signaling, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬1件: 77 💬
171Sandostatin LAR 30MG1件: Octreotide4件: Octreotide ,
Octreotide acetate ,
Octreotide pamoate ,
Octreotide acetate 💬
1件: SSTR2 💬 5件: Gastric acid secretion, Growth hormone synthesis, secretion and action, Hormone signaling, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬1件: 77 💬
172Sandostatin LAR depot1件: Octreotide4件: Octreotide ,
Octreotide acetate ,
Octreotide pamoate ,
Octreotide acetate 💬
1件: SSTR2 💬 5件: Gastric acid secretion, Growth hormone synthesis, secretion and action, Hormone signaling, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬1件: 77 💬
173Sandostatin LAR depot versus transsphenoidal surgery----1件: 77 💬
174Sandostatin LAR injection, 10MG, 20MG, 30MG1件: Octreotide4件: Octreotide ,
Octreotide acetate ,
Octreotide pamoate ,
Octreotide acetate 💬
1件: SSTR2 💬 5件: Gastric acid secretion, Growth hormone synthesis, secretion and action, Hormone signaling, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬1件: 77 💬
175Sandostatin LAR monatsdepot 20 MG----1件: 77 💬
176Sandostatin LAR ® (octreotide acetate LAR) 30 MG1件: Octreotide4件: Octreotide ,
Octreotide acetate ,
Octreotide pamoate ,
Octreotide acetate 💬
1件: SSTR2 💬 5件: Gastric acid secretion, Growth hormone synthesis, secretion and action, Hormone signaling, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬1件: 77 💬
177Sandostatin LAR, 10 MG, 20 MG and 30 MG1件: Octreotide4件: Octreotide ,
Octreotide acetate ,
Octreotide pamoate ,
Octreotide acetate 💬
1件: SSTR2 💬 5件: Gastric acid secretion, Growth hormone synthesis, secretion and action, Hormone signaling, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬1件: 77 💬
178Sandostatin LAR-monatsdepot----1件: 77 💬
179Sandostatin LAR-monatsdepot 10 MG1件: Octreotide4件: Octreotide ,
Octreotide acetate ,
Octreotide pamoate ,
Octreotide acetate 💬
1件: SSTR2 💬 5件: Gastric acid secretion, Growth hormone synthesis, secretion and action, Hormone signaling, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬1件: 77 💬
180Sandostatin LAR-monatsdepot 20 MG1件: Octreotide4件: Octreotide ,
Octreotide acetate ,
Octreotide pamoate ,
Octreotide acetate 💬
1件: SSTR2 💬 5件: Gastric acid secretion, Growth hormone synthesis, secretion and action, Hormone signaling, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬1件: 77 💬
181Sandostatin LAR-monatsdepot 30 MG1件: Octreotide4件: Octreotide ,
Octreotide acetate ,
Octreotide pamoate ,
Octreotide acetate 💬
1件: SSTR2 💬 5件: Gastric acid secretion, Growth hormone synthesis, secretion and action, Hormone signaling, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬1件: 77 💬
182Sandostatin ® injection1件: Octreotide4件: Octreotide ,
Octreotide acetate ,
Octreotide pamoate ,
Octreotide acetate 💬
1件: SSTR2 💬 5件: Gastric acid secretion, Growth hormone synthesis, secretion and action, Hormone signaling, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬1件: 77 💬
183Sandostatina - LAR 20 MG/2.5 ML polvere E solvente PER sospensione iniettabile flacone polvere + siringa preriempita 2.5 ML + 2 aghi----2件: 67, 77 💬
184Sandostatina - LAR 30 MG/2.5 ML polvere E solvente PER sospensione iniettabile flacone polvere + siringa preriempita 2.5 ML + 2 aghi----1件: 77 💬
185Sandostatina LAR----2件: 67, 77 💬
186Sandostatina LAR IM FL 20MG 2F----1件: 77 💬
187Sandostatine L.P. 30 MG, poudre ET solvant EN seringue----1件: 77 💬
188Sandostatine L.P. 30 MG, poudre ET solvant pour suspension injectable à LIBération prolongéE----1件: 77 💬
189Sandostatine LAR 20 MG----1件: 77 💬
190Sandostatine long acting repeatable 30 MG----1件: 77 💬
191Sandostatin® LAR----1件: 77 💬
192Sandostatin® LAR®-monatsdepot 10 MG1件: Octreotide4件: Octreotide ,
Octreotide acetate ,
Octreotide pamoate ,
Octreotide acetate 💬
1件: SSTR2 💬 5件: Gastric acid secretion, Growth hormone synthesis, secretion and action, Hormone signaling, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬1件: 77 💬
193Sandostatin® LAR®-monatsdepot 20 MG1件: Octreotide4件: Octreotide ,
Octreotide acetate ,
Octreotide pamoate ,
Octreotide acetate 💬
1件: SSTR2 💬 5件: Gastric acid secretion, Growth hormone synthesis, secretion and action, Hormone signaling, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬1件: 77 💬
194Sandostatin® LAR®-monatsdepot 30 MG1件: Octreotide4件: Octreotide ,
Octreotide acetate ,
Octreotide pamoate ,
Octreotide acetate 💬
1件: SSTR2 💬 5件: Gastric acid secretion, Growth hormone synthesis, secretion and action, Hormone signaling, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬1件: 77 💬
195Sign and symptoms: questionnaire----1件: 77 💬
196Signifor1件: Pasireotide3件: Pasireotide ,
Pasireotide diaspartate ,
Pasireotide pamoate 💬
4件: SSTR1,
SSTR2,
SSTR3,
SSTR5 💬
5件: Gastric acid secretion, Growth hormone synthesis, secretion and action, Hormone signaling, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬2件: 75, 77 💬
197Sitagliptin1件: Sitagliptin3件: Sitagliptin phosphate ,
Sitagliptin ,
Sitagliptin phosphate 💬
1件: DPP4 💬 2件: Protein digestion and absorption, Virion - Hepatitis viruses 💬4件: 6, 75, 77, 299 💬
198SMS995----1件: 77 💬
199SMS995B----1件: 77 💬
200SOM022----1件: 77 💬
201SOM230----3件: 74, 75, 77 💬
202SOM230 LAR----2件: 75, 77 💬
203SOM230 LAR, 20 MG----2件: 75, 77 💬
204SOM230, 300micrograms----2件: 75, 77 💬
205SOM230, 600 micrograms----2件: 75, 77 💬
206SOM230, 900 micrograms----2件: 75, 77 💬
207SOM230B----2件: 75, 77 💬
208SOM230C----2件: 75, 77 💬
209Somatostatin1件: Somatostatin1件: Somatostatin 💬 5件: SSTR1,
SSTR2,
SSTR3,
SSTR4,
SSTR5 💬
5件: Gastric acid secretion, Growth hormone synthesis, secretion and action, Hormone signaling, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬1件: 77 💬
210Somatulina autogel----1件: 77 💬
211Somatuline ATG----1件: 77 💬
212Somatuline autogel1件: Lanreotide1件: Lanreotide acetate 💬 2件: SSTR2,
SSTR5 💬
5件: Gastric acid secretion, Growth hormone synthesis, secretion and action, Hormone signaling, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬2件: 67, 77 💬
213Somatuline autogel 1201件: Lanreotide1件: Lanreotide acetate 💬 2件: SSTR2,
SSTR5 💬
5件: Gastric acid secretion, Growth hormone synthesis, secretion and action, Hormone signaling, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬1件: 77 💬
214Somatuline autogel 120 MG1件: Lanreotide1件: Lanreotide acetate 💬 2件: SSTR2,
SSTR5 💬
5件: Gastric acid secretion, Growth hormone synthesis, secretion and action, Hormone signaling, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬1件: 77 💬
215Somatuline autogel 120MG1件: Lanreotide1件: Lanreotide acetate 💬 2件: SSTR2,
SSTR5 💬
5件: Gastric acid secretion, Growth hormone synthesis, secretion and action, Hormone signaling, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬1件: 77 💬
216Somatuline autogel 60MG1件: Lanreotide1件: Lanreotide acetate 💬 2件: SSTR2,
SSTR5 💬
5件: Gastric acid secretion, Growth hormone synthesis, secretion and action, Hormone signaling, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬1件: 77 💬
217Somatuline autogel 90MG1件: Lanreotide1件: Lanreotide acetate 💬 2件: SSTR2,
SSTR5 💬
5件: Gastric acid secretion, Growth hormone synthesis, secretion and action, Hormone signaling, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬1件: 77 💬
218Somatuline autogel injectable 1201件: Lanreotide1件: Lanreotide acetate 💬 2件: SSTR2,
SSTR5 💬
5件: Gastric acid secretion, Growth hormone synthesis, secretion and action, Hormone signaling, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬1件: 77 💬
219Somatuline autogel® 60, 90 or 120 MG----1件: 77 💬
220Somatuline L.P. 120 MG, solution injectable à LIBération prolongéE EN seringue PRéremplie----1件: 77 💬
221Somatuline LP 120MG----1件: 77 💬
222Somatuline® autogel® 120 MG solution FOR injection----1件: 77 💬
223Somavert1件: Pegvisomant1件: Pegvisomant 💬 1件: GHR 💬 6件: Cytokine-cytokine receptor interaction, Growth hormone synthesis, secretion and action, Hormone signaling, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway 💬1件: 77 💬
224Somavert 10 MG1件: Pegvisomant1件: Pegvisomant 💬 1件: GHR 💬 6件: Cytokine-cytokine receptor interaction, Growth hormone synthesis, secretion and action, Hormone signaling, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway 💬1件: 77 💬
225Somavert 15 MG1件: Pegvisomant1件: Pegvisomant 💬 1件: GHR 💬 6件: Cytokine-cytokine receptor interaction, Growth hormone synthesis, secretion and action, Hormone signaling, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway 💬1件: 77 💬
226Somavert 20 MG1件: Pegvisomant1件: Pegvisomant 💬 1件: GHR 💬 6件: Cytokine-cytokine receptor interaction, Growth hormone synthesis, secretion and action, Hormone signaling, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway 💬1件: 77 💬
227Subcutaneous administration OF recombinant human IGF-1----1件: 77 💬
228Surgery FOR acromegaly----1件: 77 💬
229SYHX2008 injection----1件: 77 💬
230Tadalafil1件: Tadalafil1件: Tadalafil 💬 1件: PDE5 💬 2件: Purine metabolism, cGMP-PKG signaling pathway 💬7件: 6, 51, 75, 77, 84, 86, 113 💬
231TE-8214 - SAD----1件: 77 💬
232Thyroid sonography----1件: 77 💬
233Total body magnetic resonance imaging----1件: 77 💬
234Transcranial magnetic stimulation----3件: 6, 13, 77 💬
235Transnasal butterfly surgery----1件: 77 💬
236Transsphenoidal adenomectomy----1件: 77 💬
237Transsphenoidal surgery----1件: 77 💬
238TRP----3件: 46, 75, 77 💬
239TYR----3件: 75, 77, 298 💬
240UNK----1件: 77 💬
241Zoledronic acid1件: Zoledronic acid5件: Zoledronic acid ,
Zoledronate disodium ,
Zoledronate trisodium ,
Zoledronic acid ,
Zoledronic acid hemipentahydrate 💬
1件: FDPS 💬 3件: Human T-cell leukemia virus 1 infection, Influenza A, Terpenoid backbone biosynthesis 💬13件: 6, 13, 46, 75, 77, 93, 95, 96, 97, 270, 274, 299, 333 💬